Skip to main content

Articles

Page 14 of 29

  1. We experienced a rare case of immediate type hypersensitivity and late phase reaction to anti-tubercular therapy consisting of ethambutol and levofloxacin, which occurred in close succession, giving the appear...

    Authors: Yukihiko Kato, Yu Sato, Miho Nakasu and Ryoji Tsuboi
    Citation: Allergy, Asthma & Clinical Immunology 2018 14:13
    Content type: Case report Published on:

  3. Tuberculosis induced autoimmune haemolytic anaemia is a rare entity. The aim of this study was to explore its common presentations, investigation findings and treatment options through a systematic review of p...

    Authors: Devarajan Rathish and Sisira Siribaddana
    Citation: Allergy, Asthma & Clinical Immunology 2018 14:11
    Content type: Review Published on:

  4. Malaria and helminths share the same geographical distribution in tropical Africa. Studies of the interaction of helminth and malaria co-infection in humans have been few and are mainly epidemiological, with l...

    Authors: Richard Bwanika, Charles D. Kato, Johnson Welishe and Daniel C. Mwandah
    Citation: Allergy, Asthma & Clinical Immunology 2018 14:10
    Content type: Research Published on:

  5. Recombinant human erythropoietin, such as epoetin alfa and darbepoetin alfa, is an important therapy for anemia due to chronic renal failure. Allergy to recombinant human erythropoietin and the need for desens...

    Authors: Jaime S. Rosa, Van B. Vuong, Orly Haskin and Anne Y. Liu
    Citation: Allergy, Asthma & Clinical Immunology 2018 14:8
    Content type: Case report Published on:

  6. T cells play a central role in chronic inflammation in asthma. However, the roles of individual subsets of T cells in the pathology of asthma in patients remain to be better understood.

    Authors: Matthew Wiest, Katherine Upchurch, Wenjie Yin, Jerome Ellis, Yaming Xue, Bobby Lanier, Mark Millard, HyeMee Joo and SangKon Oh
    Citation: Allergy, Asthma & Clinical Immunology 2018 14:7
    Content type: Research Published on:

  8. Group 2 innate lymphoid cells (ILC2s) are a newly identified cell population with the potent capability to produce Th2-type cytokines in a non-antigen specific manner. Previous study demonstrated that enhanced...

    Authors: Qing Miao, Yan Wang, Yong-ge Liu, Yi-xin Ren, Hui Guan, Zhen Li, Wei Xu and Li Xiang
    Citation: Allergy, Asthma & Clinical Immunology 2018 14:6
    Content type: Research Published on:

  9. Atopic allergy is a widespread disease with increasing prevalence in the second half of the twentieth century and is most often associated with clinical symptoms, like rhinoconjunctivitis, asthma or eczema. Th...

    Authors: Lukas Steinegger, Stephan Regenass, Lucas M. Bachmann, Elsbeth Probst and Urs C. Steiner
    Citation: Allergy, Asthma & Clinical Immunology 2018 14:4
    Content type: Research Published on:

  10. The prevalence of adverse food reactions in patients with chronic inhalant diseases has seldom been studied in China. This study is to investigate the prevalence of adverse food reactions and the symptoms caus...

    Authors: Guodong Hao, Xuxin Lai, Zhijing Song, Zhixing Wang, Xing-ai Kong, Haifeng Zhong, Sui Fu Hui and Yiwu Zheng
    Citation: Allergy, Asthma & Clinical Immunology 2018 14:3
    Content type: Research Published on:

  11. Loratadine is a second-generation, non-sedating antihistamine used for the relief of allergic rhinitis symptoms. Previous studies reported that when loratadine was encapsulated, the onset of action for symptom...

    Authors: Mark W. Tenn, Lisa M. Steacy, Charlene C. Ng and Anne K. Ellis
    Citation: Allergy, Asthma & Clinical Immunology 2018 14:5
    Content type: Research Published on:

  13. Contribution of nitric-oxide (NO) pathway to the pathogenesis of bronchial asthma (asthma) is ambiguous as NO may confer both protective and detrimental effects depending on the NO synthase (NOS) isoforms, tis...

    Authors: Gabor Tajti, Csaba Papp, Laszlo Kardos, Sandor Keki, Krisztian Pak, Magdolna Emma Szilasi, Rudolf Gesztelyi, Angela Mikaczo, Andrea Fodor, Maria Szilasi and Judit Zsuga
    Citation: Allergy, Asthma & Clinical Immunology 2018 14:2
    Content type: Research Published on:

  14. Clinical trials using oral immunotherapy (OIT) for the treatment of food allergies have shown promising results. We previously demonstrated the feasibility of desensitization for up to 5 food allergens simulta...

    Authors: Sandra Andorf, Monali Manohar, Tina Dominguez, Whitney Block, Dana Tupa, Rohun A. Kshirsagar, Vanitha Sampath, R. Sharon Chinthrajah and Kari C. Nadeau
    Citation: Allergy, Asthma & Clinical Immunology 2017 13:52
    Content type: Research Published on:

  15. A number of clinical studies focused on treating a single food allergy through oral immunotherapy (OIT) with adjunctive omalizumab treatment have been published. We previously demonstrated safety and tolerabil...

    Authors: Sandra Andorf, Monali Manohar, Tina Dominguez, Whitney Block, Dana Tupa, Rohun A. Kshirsagar, Vanitha Sampath, R. Sharon Chinthrajah and Kari C. Nadeau
    Citation: Allergy, Asthma & Clinical Immunology 2017 13:51
    Content type: Research Published on:

  16. Although influenza vaccines are generally safe and effective, a variety of autoimmune phenomena have been reported after vaccination over the past years, such as Guillain–Barre syndrome, rheumatoid arthritis, ...

    Authors: Stefanie Eindhoven, Jolien Levels, Margriet Huisman, Koos Ruizeveld de Winter, Virgil Dalm and Rehmat Alwani
    Citation: Allergy, Asthma & Clinical Immunology 2017 13:49
    Content type: Case Report Published on:

  17. Immunoglobulin therapy plays a critical role in the treatment of immunodeficiency disorders as well as autoimmune and inflammatory conditions. In immunodeficient patients, there has been controversy whether in...

    Authors: Rohan Ameratunga
    Citation: Allergy, Asthma & Clinical Immunology 2017 13:47
    Content type: Case Report Published on:

  18. The castor bean plant, Ricinus communis, is known to have allergenic and toxic properties. Castor bean allergy has been described mainly as an occupational inhalation allergy in laboratory workers, in persons wor...

    Authors: Y. Coattrenec, D. Jaques, P. Jandus, T. Harr and D. Spoerl
    Citation: Allergy, Asthma & Clinical Immunology 2017 13:50
    Content type: Case Report Published on:

  19. The heterogeneous nature of asthma has been understood for decades, but the precise categorization of asthma has taken on new clinical importance in the era of specific biologic therapy. The simple categories ...

    Authors: Harold Kim, Anne K. Ellis, David Fischer, Mary Noseworthy, Ron Olivenstein, Kenneth R. Chapman and Jason Lee
    Citation: Allergy, Asthma & Clinical Immunology 2017 13:48
    Content type: Review Published on:

  23. Precautionary allergen labelling (PAL) has resulted in consumer confusion. Previous research has shown that interpretive labels (using graphics, symbols, or colours) are better understood than the traditional ...

    Authors: Giovanni A. Zurzolo, Rachel L. Peters, Jennifer J. Koplin, Maximilian de Courten, Michael L. Mathai and Katrina J. Allen
    Citation: Allergy, Asthma & Clinical Immunology 2017 13:42
    Content type: Letter to the Editor Published on:

  25. Allergic, especially anaphylactic, reactions during immunoglobulin replacement therapy are rare, but their pathophysiology and classification remain ambiguous. Recent findings show positive results of skin tes...

    Authors: Przemyslaw Zdziarski, Andrzej Gamian, Jacek Majda and Agnieszka Korzeniowska-Kowal
    Citation: Allergy, Asthma & Clinical Immunology 2017 13:41
    Content type: Case Report Published on:

    The Correction to this article has been published in Allergy, Asthma & Clinical Immunology 2018 14:62

  26. The prevalence of adverse food reactions (AFR) has been increasing in the western world. Clinical manifestations are diversified and it may not be possible to clinically discriminate between IgE and non-IgE me...

    Authors: Arminda Jorge, Elisa Soares, Emanuel Sarinho, Felix Lorente, Jorge Gama and Luís Taborda-Barata
    Citation: Allergy, Asthma & Clinical Immunology 2017 13:40
    Content type: Research Published on:

  27. Omalizumab is a human IgG1 antibody against IgE used as a therapy for sever asthmatic patients with asthma. According to the guidelines of the Global Initiative for Asthma, omalizumab is an add-on drug at trea...

    Authors: Yasuhiro Gon, Reiko Ito, Shuichiro Maruoka, Kenji Mizumura, Yutaka Kozu, Hisato Hiranuma, Yuko Iida, Sotaro Shikano and Shu Hashimoto
    Citation: Allergy, Asthma & Clinical Immunology 2017 13:39
    Content type: Case report Published on:

  28. Treat-to-target therapy approaches are established for chronic diseases such as diabetes, hypertension, and more recently rheumatoid arthritis, resulting in improved patient outcomes. These approaches do not u...

    Authors: Hermenio Lima, Melinda Gooderham, Jan Dutz, Charles Lynde, Hugo Chapdelaine, Anne Ellis, Martin Gilbert, Vincent Ho, Kim Papp, Yves Poulin and Gordon Sussman
    Citation: Allergy, Asthma & Clinical Immunology 2017 13:38
    Content type: Short Report Published on:

  29. Sleep disorders are often underreported to physicians by patients with allergies. This study aimed to characterize the sleep disorders associated with respiratory allergy to house dust mites (HDM) at the time ...

    Authors: Damien Leger, Bénédicte Bonnefoy, Bernard Pigearias, Bertrand de La Giclais and Antoine Chartier
    Citation: Allergy, Asthma & Clinical Immunology 2017 13:36
    Content type: Research Published on:

  30. To evaluate barrier protective properties of Rhinosectan® spray, a medical device containing xyloglucan, on nasal epithelial cells (MucilAir).

    Authors: Barbara De Servi, Francesco Ranzini and Núria Piqué
    Citation: Allergy, Asthma & Clinical Immunology 2017 13:37
    Content type: Research Published on:

  31. Intelectin-1 (ITLN-1) is secreted by intestinal goblet cells and detectable in blood. Its expression is increased in IL-13-overexpressing mouse airways. However, its expression and function in human airways is...

    Authors: Taiji Watanabe, Kazuyuki Chibana, Taichi Shiobara, Rinna Tei, Ryosuke Koike, Yusuke Nakamura, Ryo Arai, Yukiko Horigane, Yasuo Shimizu, Akihiro Takemasa, Takeshi Fukuda, Sally E. Wenzel and Yoshiki Ishii
    Citation: Allergy, Asthma & Clinical Immunology 2017 13:35
    Content type: Research Published on:

  32. Omalizumab is licensed as add-on therapy for patients with severe allergic asthma. Response is in most studies scored by the physician’s global evaluation of treatment effectiveness (GETE). A good clinical and...

    Authors: S. M. Snelder, E. J. M. Weersink and G. J. Braunstahl
    Citation: Allergy, Asthma & Clinical Immunology 2017 13:34
    Content type: Research Published on:

  33. There is a paucity of studies examining the safety of venom immunotherapy (VIT) in children. We aimed to assess the incidence of anaphylactic side effects during rush VIT in a cohort of pediatric patients and ...

    Authors: Johanna Stoevesandt, Christine Hosp, Andreas Kerstan and Axel Trautmann
    Citation: Allergy, Asthma & Clinical Immunology 2017 13:32
    Content type: Research Published on:

  35. Patients with hereditary angioedema (HAE) due to C1-inhibitor deficiency (C1-INH-HAE) experience recurrent attacks of cutaneous or submucosal edema that may be frequent and severe; prophylactic treatments can ...

    Authors: Werner Aberer, Marcus Maurer, Laurence Bouillet, Andrea Zanichelli, Teresa Caballero, Hilary J. Longhurst, Amandine Perrin and Irmgard Andresen
    Citation: Allergy, Asthma & Clinical Immunology 2017 13:31
    Content type: Research Published on:

  37. Authors: Alvin H. Schmaier, Marco Cicardi, Avner Reshef, Dumitru Moldovan, Attila Mócsai, Margarita López-Trascasa, Alberto López Lera, Nancy J. Brown, Anastasios E. Germenis, Rafael Filippelli-Silva, Diego A. Duarte, Renan P. Martin, Camila L. Veronez, Michel Bouvier, Michael Bader, Claudio M. Costa-Neto…
    Citation: Allergy, Asthma & Clinical Immunology 2017 13(Suppl 2):29
    Content type: Meeting abstracts Published on:

    This article is part of a Supplement: Volume 13 Supplement 2

  39. Asthma is an independent risk factor for invasive pneumococcal disease; however, the immune response of adult asthma patients to pneumococcal vaccination is unknown. We explore the serologic response of patien...

    Authors: C. R. Laratta, K. Williams, D. Vethanayagam, M. Ulanova and H. Vliagoftis
    Citation: Allergy, Asthma & Clinical Immunology 2017 13:27
    Content type: Research Published on:

  40. Many studies have identified associations between qualities of maternal–child relationships and childhood asthma, but few have examined associations with childhood atopic dermatitis (AD), a common precursor to...

    Authors: Nicole L. Letourneau, Anita L. Kozyrskyj, Nela Cosic, Henry N. Ntanda, Lubna Anis, Martha J. Hart, Tavis S. Campbell and Gerald F. Giesbrecht
    Citation: Allergy, Asthma & Clinical Immunology 2017 13:26
    Content type: Research Published on:

  41. Up-regulation of interleukin 17 (IL-17) family cytokines and acute phase response have been observed in patients with chronic spontaneous urticaria (CSU). It has been demonstrated that IL-17 stimulates C-react...

    Authors: A. Grzanka, A. Damasiewicz-Bodzek and A. Kasperska-Zajac
    Citation: Allergy, Asthma & Clinical Immunology 2017 13:25
    Content type: Research Published on:

  42. Success in asthma management hinges on patients’ competency to detect and respond to ever-changing symptom severity. Thus, it is crucial to have reliable, simple, and sustainable methods of symptom monitoring ...

    Authors: Hyekyun Rhee, Michael Belyea and Jennifer Mammen
    Citation: Allergy, Asthma & Clinical Immunology 2017 13:24
    Content type: Research Published on:

  43. Mastocytosis are rare diseases characterized by an accumulation of clonal mast cells (MCs) in one or multiple organs or tissues. Patients with systemic mastocytosis (SM), whose MCs frequently arbor the activat...

    Authors: Iolanda Conde-Fernandes, Rita Sampaio, Filipa Moreno, José Palla-Garcia, Maria dos Anjos Teixeira, Inês Freitas, Esmeralda Neves, Maria Jara-Acevedo, Luis Escribano and Margarida Lima
    Citation: Allergy, Asthma & Clinical Immunology 2017 13:21
    Content type: Case Report Published on:

  44. Interleukin-31 (IL-31) is a recently identified cytokine produced by Th2 cells that is involved in the development of atopic dermatitis-induced skin inflammation and pruritus. Its receptor, IL-31RA, is express...

    Authors: Saburo Saito, Ayana Aoki, Iwao Arai, Shinya Takaishi, Haruyasu Ito, Nobutake Akiyama and Hiroshi Kiyonari
    Citation: Allergy, Asthma & Clinical Immunology 2017 13:23
    Content type: Research Published on:

  45. The mechanisms through which allergies can be inhibited after preconception immunization with allergens are not fully understood. We aimed to evaluate whether maternal immunization can induce a regulatory B (B...

    Authors: Marília Garcia de Oliveira, Luana de Mendonça Oliveira, Aline Aparecida de Lima Lira, Fábio da Ressureição Sgnotto, Alberto José da Silva Duarte, Maria Notomi Sato and Jefferson Russo Victor
    Citation: Allergy, Asthma & Clinical Immunology 2017 13:22
    Content type: Research Published on:

  46. Authors: Mohammad A. Alsayegh, Hanan Alshamali, Mousa Khadada, Amanda Ciccolini, Anne K. Ellis, Diana Quint, William Powley, Laurie Lee, Yahya Fiteih, Shairaz Baksh, Harissios Vliagoftis, Sebastien K. Gerega, Brad Millson, Katia Charland, Stephane Barakat, Xichun Sun…
    Citation: Allergy, Asthma & Clinical Immunology 2017 13(Suppl 1):16
    Content type: Meeting abstracts Published on:

    This article is part of a Supplement: Volume 13 Supplement 1

  48. Food allergen labeling is an important tool to reduce risk of exposure and prevent anaphylaxis for individuals with food allergies. Health Canada released a Canadian food allergen labeling regulation (2008) an...

    Authors: Carlo A. Marra, Stephanie Harvard, Maja Grubisic, Jessica Galo, Ann Clarke, Susan Elliott and Larry D. Lynd
    Citation: Allergy, Asthma & Clinical Immunology 2017 13:19
    Content type: Research Published on:

  49. Antagonism of chemoattractant receptor-homologous molecule on T-helper type-2 cells (CRTH2), a G-protein coupled receptor for prostaglandin D2, could be beneficial for treating allergic disorders. We present f...

    Authors: Paul Ratner, Charles P. Andrews, Frank C. Hampel, Bruce Martin, Dale E. Mohar, Denis Bourrelly, Parisa Danaietash, Sara Mangialaio, Jasper Dingemanse, Abdel Hmissi and Jay van Bavel
    Citation: Allergy, Asthma & Clinical Immunology 2017 13:18
    Content type: Research Published on:

  50. Prednisone dependence in asthma is usually described based on clinical and spirometric characteristics. It is generally believed that these patients have frequent exacerbations and lose lung function rapidly b...

    Authors: Afia Aziz-Ur-Rehman, Angira Dasgupta, Melanie Kjarsgaard, Frederick E. Hargreave and Parameswaran Nair
    Citation: Allergy, Asthma & Clinical Immunology 2017 13:17
    Content type: Research Published on:

The official journal of CSACI

Submit manuscript

Annual Journal Metrics

  • 2022 Citation Impact
    2.7 - 2-year Impact Factor
    3.4 - 5-year Impact Factor
    0.989 - SNIP (Source Normalized Impact per Paper)
    0.634 - SJR (SCImago Journal Rank)

    2023 Speed
    19 days submission to first editorial decision for all manuscripts (Median)
    140 days submission to accept (Median)

    2023 Usage 
    1,545,686 downloads
    2,123 Altmetric mentions

Allergy, Asthma & Clinical Immunology

ISSN: 1710-1492

Contact us